Treatment of microarray experiments as split-plot designs.

J Biopharm Stat

Statistical Sciences NA, GlaxoSmithKline, Research Triangle Park, North Carolina, USA.

Published: May 2003

This paper shows that microarray experiments are split-plot, or split-unit, designs. The larger size experimental unit (the whole plot) is the array, and the treatment applied to this unit is the treatment given to the cells which produce the cDNA that is hybridized to the array. The smaller size experimental unit (the subplot) is the spot on the array, and the treatment applied to this unit is the gene giving rise to the DNA or oligonucleotide attached at that spot. Various treatment and design structures can be applied to the whole plot and the subplot; we consider the model equations appropriate to different designs. Preliminary normalization of the data can be avoided by including appropriate blocking terms in the model equation. We show how conventional analysis of variance can be used to test for significant differences in expression, and consider multiplicity corrections and graphical methods for identifying important expression differences.

Download full-text PDF

Source
http://dx.doi.org/10.1081/BIP-120019264DOI Listing

Publication Analysis

Top Keywords

microarray experiments
8
experiments split-plot
8
size experimental
8
experimental unit
8
array treatment
8
treatment applied
8
applied unit
8
treatment
5
treatment microarray
4
split-plot designs
4

Similar Publications

Background: Spinal cord injury (SCI) triggers a complex inflammatory response that impedes neural repair and functional recovery. The modulation of macrophage phenotypes is thus considered a promising therapeutic strategy to mitigate inflammation and promote regeneration.

Methods: We employed microarray and single-cell RNA sequencing (scRNA-seq) to investigate gene expression changes and immune cell dynamics in mice following crush injury at 3 and 7 days post-injury (dpi).

View Article and Find Full Text PDF

Lymph node metastasis significantly affects the NSCLC patients' staging, treatment strategy, and prognosis. Studies have shown that IGF2BP3, an oncofetal protein and an m6A reader, overexpresses and correlates to lymph node metastasis and worse overall survival in histopathological studies including NSCLC, but its mechanism needs further study. This study explored IGF2BP3's function and mechanism in LUAD lymphatic metastasis using public databases, a human LUAD tissue microarray, human LUAD cells, and a lymphatic metastasis model in male BALB/c nude mice.

View Article and Find Full Text PDF

Introduction: Mesenchymal stem cell (MSC)-based therapies have emerged as a promising approach for treating articular cartilage injuries. However, enhancing the chondrogenic differentiation potential of MSCs remains a significant challenge. KDM6B, a histone demethylase that specifically removes H3K27me3 marks, is essential in controlling the maturation of chondrocytes.

View Article and Find Full Text PDF

Background: Ferroptosis and immune responses are critical pathological events in spinal cord injury (SCI), whereas relative molecular and cellular mechanisms remain unclear.

Methods: Micro-array datasets (GSE45006, GSE69334), RNA sequencing (RNA-seq) dataset (GSE151371), spatial transcriptome datasets (GSE214349, GSE184369), and single cell RNA sequencing (scRNA-seq) datasets (GSE162610, GSE226286) were available from the Gene Expression Omnibus (GEO) database. Through weighted gene co-expression network analysis and differential expression analysis in GSE45006, we identified differentially expressed time- and immune-related genes (DETIRGs) associated with chronic SCI and differentially expressed ferroptosis- and immune-related genes (DEFIRGs), which were validated in GSE151371.

View Article and Find Full Text PDF

Unraveling the potential mechanism and prognostic value of pentose phosphate pathway in hepatocellular carcinoma: a comprehensive analysis integrating bulk transcriptomics and single-cell sequencing data.

Funct Integr Genomics

January 2025

Institute of Infectious Diseases, Guangdong Province, Guangzhou Eighth People's Hospital, Guangzhou Medical University, 8 Huaying Road, Baiyun District, Guangzhou, 510440, China.

Hepatocellular carcinoma (HCC) remains a malignant and life-threatening tumor with an extremely poor prognosis, posing a significant global health challenge. Despite the continuous emergence of novel therapeutic agents, patients exhibit substantial heterogeneity in their responses to anti-tumor drugs and overall prognosis. The pentose phosphate pathway (PPP) is highly activated in various tumor cells and plays a pivotal role in tumor metabolic reprogramming.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!